Can bone scan be spared in asymptomatic prostate cancer patients at the initial stage of diagnosis?

Xue-yi XUE,Wu-lin FAN,Ning XU,Shao-hao CHEN,Hui-jun CHEN,Hai Cai,Xiao-dong LI,Yong WEI,ZHENGQing-shui,Xiong-lin SUN

DOI: https://doi.org/10.3870/j.issn.1674-4624.2014.06.009

2014-01-01

Abstract:Objective To investigate if it is suitable for our country to set prostate-specific an-tigen (PSA)level<20 ng/ml and Gleason score<8 as the cut point below which a bone scan can be spared in prostate cancer patients with no symptoms of bone metastases,and the suitable cut point for us. Methods We retrospectively reviewed the charts of 257 consecutive patients with a pathol-ogy diagnosis of prostate cancer hospitalized in our department between May.2003 and Dec.2012, and evaluated age,serum tPSA,Gleason sum and bone scan. Results 67 (26.1%)patients got positive results.The serum PSA levels and Gleason score were significantly higher (P<0.05)in patients with positive results of the bone scan than those with negative results.With the increase of PSA level and Gleason score,the incidence of bone metastasis increased (P<0.05).Univariate and multivariate logistic regression analyses suggested that PSA level and Gleason score were independent predictors of bone metas-tasis.None of the 35 patients with PSA level<10 ng/ml and Gleason score ≤6 had positive results (negative predictive value was 100%),3 of 81 patients with the PSA level <20 ng/ml and Gleason score<8 had positive results (negative predictive value was 96.3%). Conclusions PSA level and Gleason score are independent predictors of bone metastasis.It is suitable for our country to set PSA level<10 ng/ml and Gleason score≤6 as the cut point below which a bone scan can be spared in prostate cancer patients with no symptoms of bone metastases,but not the PSA level<20 ng/ml and Gleason score<8.